A multicenter, retrospective, cohort study assessing effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine
Latest Information Update: 21 Oct 2021
At a glance
- Drugs Fremanezumab (Primary) ; Galcanezumab (Primary)
- Indications Migraine; Migraine with aura
- Focus Therapeutic Use
- 21 Oct 2021 New trial record
- 13 Oct 2021 Results published in the Cephalalgia